Regulation of activity-dependent dendritic vasopressin release from rat supraoptic neurones.
Magnocellular neurones of the hypothalamus release vasopressin and oxytocin from their dendrites and soma. Using a combination of electrophysiology, microdialysis, in vitro explants, and radioimmunoassay we assessed the involvement of intracellular Ca(2+) stores in the regulation of dendritic vasopressin release. Thapsigargin and cyclopiazonic acid, which mobilize Ca(2+) from intracellular stores of the endoplasmic reticulum, evoked vasopressin release from dendrites and somata of magnocellular neurones in the supraoptic nucleus. Thapsigargin also produced a dramatic potentiation of dendritic vasopressin release evoked by osmotic or high potassium stimulation. This effect is long lasting, time dependent, and specific to thapsigargin as caffeine and ryanodine had no effect. Furthermore, antidromic activation of electrical activity in the cell bodies released vasopressin from dendrites only after thapsigargin pretreatment. Thus, exposure to Ca(2+) mobilizers such as thapsigargin or cyclopiazonic acid primes the releasable pool of vasopressin in the dendrites, so that release can subsequently be evoked by electrical and depolarization-dependent activation. Vasopressin itself is effective in inducing dendritic vasopressin release, but it is ineffective in producing priming.
Ludwig
Mike
M
Centre for Integrative Physiology, University of Edinburgh, George Square, Edinburgh EH8 9XD, UK. mike.ludwig@ed.ac.uk
Bull
Philip M
PM
Tobin
Vicky A
VA
Sabatier
Nancy
N
Landgraf
Rainer
R
Dayanithi
Govindan
G
Leng
Gareth
G
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology; D003712:Dendrites / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D013495:Supraoptic Nucleus / Q000187:drug effects / Q000378:metabolism*; D019284:Thapsigargin / Q000494:pharmacology; D014667:Vasopressins / Q000378:metabolism*
D002121:Calcium Channel Blockers; D014667:Vasopressins; D019284:Thapsigargin
Nature. 2002 Jul 4;418(6893):85-9
12097911
Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):150-76
15589267
Trends Neurosci. 2003 May;26(5):255-61
12744842
J Neurosci. 2003 Nov 12;23(32):10351-8
14614094
Eur J Neurosci. 2004 May;19(10):2909-12
15147325
J Neurosci. 1999 Nov 1;19(21):9235-41
10531427
Neuron. 1999 Dec;24(4):979-88
10624960
Exp Physiol. 2000 Mar;85 Spec No:131S-138S
10795915
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):337-42
11120892
J Chem Neuroanat. 2002 Mar;23(3):171-86
11861124
Front Neuroendocrinol. 2002 Apr;23(2):200-24
11950245
J Physiol. 2004 Jul 1;558(Pt 1):161-80
15146047
J Physiol. 2004 Sep 1;559(Pt 2):611-24
15254151
J Physiol. 1985 Dec;369:45-60
4093889
Exp Brain Res. 1989;76(3):593-602
2792248
Neuroscience. 1989;32(2):435-9
2586758
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2466-70
2138778
J Physiol. 1994 Jul 15;478 ( Pt 2):275-87
7525943
J Neuroendocrinol. 1994 Aug;6(4):369-73
7987366
Eur J Neurosci. 1995 Apr 1;7(4):592-8
7620610
J Neuroendocrinol. 1995 Apr;7(4):243-53
7647766
Neuron. 1995 Sep;15(3):637-47
7546743
J Physiol. 1996 Feb 1;490 ( Pt 3):713-27
8683470
Prog Neurobiol. 1995 Nov-Dec;47(4-5):291-339
8966209
Neurosci Biobehav Rev. 1996 Autumn;20(3):341-58
8880728
J Biol Chem. 1997 Jan 31;272(5):2794-800
9006919
J Physiol. 1997 Sep 1;503 ( Pt 2):253-68
9306270
Neuron. 1997 Oct;19(4):903-12
9354336
J Neurosci. 1998 Mar 1;18(5):1879-85
9465012
Eur J Neurosci. 1997 Dec;9(12):2532-40
9517458
Cell Mol Neurobiol. 1998 Feb;18(1):13-28
9524727
Brain Res. 1998 Feb 23;785(1):178-82
9526078
Neuron. 1998 Apr;20(4):749-61
9581766
J Neurosci. 1998 Nov 15;18(22):9480-8
9801385
J Neuroendocrinol. 1998 Dec;10(12):881-95
9870745
Neuroreport. 1999 Jun 3;10(8):1735-9
10501566
Cell Calcium. 2005 Jan;37(1):45-56
15541463
J Neurosci. 2002 Oct 15;22(20):9063-9
12388613